Atlas Trials

Clinical Study on the Safety, Efficacy and Pharmacokinetics of Telpegfilgrastim in Pediatric Cancer Patients with Chemotherapy

Clinical trial NCT06857292 · RECRUITING

Trial details

NCT number
NCT06857292
Sponsor
Sun Yat-sen University
Status
RECRUITING
Phase
Phase 2
Study type
INTERVENTIONAL
Chemotherapy-Induced Neutropenia
Start date
2024-12-01
Primary completion
2025-12-01
Enrollment
97

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.